Skip to main content

Report: Health Care to be Major Driver of Houston Economy in Years Ahead

Published Oct 28, 2020 by A.J. Mistretta

GHP_Maternal Health Care_Medical

Over the next 16 years, about 1 in 4 of all new jobs added in the Houston region will be in the health care sector, but not properly preparing the workforce pipeline for those positions could cost the region billions. 

According to a new report from Center for Houston’s Future, the health care sector is likely to generate a baseline GDP of $26 billion for the region by 2036. But failing to adequately develop the talent pipeline to assume new jobs in the industry could cost Houston $18.6 billion in lost GDP and 111,000 potential jobs, the 62-page report found. 

The report, Houston’s Economic Future: Health Care, focusing on both the economic vitality of the region’s health care system and assessing our community’s health. 

Focusing on cultivating the region’s life sciences sector could yield an additional $13 billion in GDP and 73,000 additional jobs by 2036, the report found. 

The Center developed a unique economic forecasting tool to analyze the impact of various health-care-related scenarios on the region’s future employment growth and GDP. The organization conducted two surveys—one pre-Covid-19 in January and another in September—with regional employers. More than 50 health care experts contributed via focus groups and interviews, and some 100 executives in Greater Houston completed the Center’s health care surveys. 

The report profiles community health in the region, including outcomes and access to care. It discusses key trends currently reshaping how health care will be delivered and funded. These include telehealth and artificial intelligence.

The report details findings from the survey, including:

  • Employers widely see Covid-19 as a transformational event that will reshape the entire health care system. 
  • 59% of respondents said the pandemic has made them more likely to support an expansion of Medicaid in Texas.
  • The pandemic has drastically changed employers’ projections of how their health care costs will rise. In January, four in 10 expected costs to rise by over 10% in the next five years. Today, 65% believe this will be the case.

The report also includes a reflection on lessons learned from the region’s response to Covid-19, including:

  • Promoting health equity will facilitate a better pandemic response. Foremost, this means reducing the number of uninsured in Houston.
  • Adopting models of providing care such as value-based care would strengthen the region’s ability to weather a crisis by transferring financial risk from providers to payors.

In light of the report’s findings, the Center acknowledged that a coordinated public health response and thriving health system requires collaboration across the region’s many hospital systems and stakeholders.
Such coordination will also require leadership from the business community. The Center said future policies must address so-called social determinants of health, such as race and income. 

“We hope that this report sparks a community-wide discussion on how Greater Houston can become a model for the country for developing a health care system that provides affordable and accessible care, delivers increased quality, is cost efficient and drives economic growth,” said Brett Perlman, the Center’s president and CEO. 

The report was made possible with funding from HCA Houston Healthcare. 

View the complete report and learn more about life sciences in the Houston region. 
 

Related News

Health Care

University of Houston, Baylor College of Medicine to Launch Cutting-Edge Research Hub

8/26/24
The University of Houston (UH) and Baylor College of Medicine (BCM) have been awarded a $44.2 million grant from the National Center for Advancing Translational Research. This funding will support the establishment of a regional hub dedicated to advancing clinical and translational research.  Dubbed the Consortium for Translational and Precision Health (CTPH), the new hub will enhance collaboration between the two institutions and other clinical and research groups within the Texas Medical Center. The CTPH aims to expedite the translation of new technologies and discoveries into patient care and real-world impact, provide funding and resources to accelerate pilot projects and research initiatives and connect investigators with local healthcare organizations and government agencies that are dedicated to healthcare, clinical research and policy.  “Research is the engine empowering health care’s life-changing advancements,” said UH President Renu Khator, in a release. “This innovative hub will be a catalyst for groundbreaking discoveries and treatments that improve people’s quality of life. That’s what drives us at UH and we’re ecstatic to cofound a regional hub for change alongside Baylor.”  The hub will be led by BCM’s Christopher Amos, professor and director of the Institute for Clinical and Translational Research, and Dr. Fasiha Kanwal, professor of medicine and chief of the section of gastroenterology and hepatology, alongside UH’s Dr. Bettina M. Beech, clinical professor of population health and chief population health officer.  “The CTPH is a partnership that draws on strengths of both institutions, creating a rich multidisciplinary environment. It will act as the vehicle to enhance the infrastructure and resources needed to effectively conduct research and implement solutions to advance healthcare,” said Dr. Carolyn Smith, interim senior vice president and dean of research at BCM. “It will help implement and create ongoing core research activities that will support the clinical translational science at both institutions.”  This strategic partnership comes at a time when local institutions are intensifying efforts to advance critical research that will deliver vital healthcare solutions. The University of Texas MD Anderson Cancer Center and Rice University recently announced a collaboration to advance fundamental and translational cancer research and develop life-saving technologies. Additionally, a research initiative led by Rice University, in collaboration with MD Anderson, received an $18 million grant to improve tumor removal technology for breast, head and neck cancer.  Learn more about Houston’s Life Sciences industry. 
Read More
Economic Development

Houston's Life Sciences Sector on the Verge of a New Era

2/27/24
Houston continues to evolve as a premier destination for life sciences and biomanufacturing through a multifaceted strategy that capitalizes on its existing strengths and fosters innovation and growth.   Since its inception in 1945, the Texas Medical Center has evolved into a vast medical district spanning 5 square miles  and serving over ten million patients annually.  More than 60 institutions operate within the Texas Medical Center, serving as a catalyst for Houston’s collaborative ecosystem, with efforts like the Cell Therapy Manufacturing Center, JLABS@TMC and CUBIO. This helps set the stage for groundbreaking research and provides direct access to nearly 5,000 active clinical trials, a major boon to innovation.   Recent years have witnessed significant strides in laying a robust foundation for Houston's position as a leader in innovative life sciences and biotechnology. These efforts came into focus last month at Bisnow’s Life Sciences Evolution event, with leaders in the life sciences industry, real estate and innovation envisioning the future growth of the Houston life sciences market. Among the assets shared as advantages were access to clinical trials, business environment, workforce efforts and quality of life.   “Having access to the patient population is critical to success, especially a diverse population,” Monique Knighten, PhD of Portal Innovations said. “There’s a key benefit to have access to these clinical trials and the expertise involved, as well as living close to where the science is being developed.”   Legislative actions, such as the passage of Proposition 10 in November which provides new incentives for medical device and pharmaceutical manufacturing companies, enhances the region's competitiveness and economic prospects. Additionally, investments in workforce development, exemplified by collaborations between educational institutions and industry partners like San Jacinto College and the National Institute for Bioprocessing Research and Training (NIBRT), ensure a skilled talent pool for the future.  “The relationships with companies, colleges and high schools are integral,” Pearland EDC Vice President Brian Malone said on the panel at Bisnow discussing suburban life sciences growth. “We’ve really worked hard on that with a business retention plan to find out what type of training and what type of workers these companies need.”   Furthermore, substantial real estate investments further support life sciences research and development. TMC’s Helix Park opened in 2023 with the TMC Collaborative Building and industry research hub Dynamic One, with new tenant Houston Methodist leasing 75,800 square feet. Just north inside the Medical District, Hines’ Levit Green is now leasing nearly 300,000 square feet of purpose-built lab and office space as part of a future 53-acre district. On the northeast side of the metro, McCord’s master-planned Generation Park recently broke ground on a new Center for Biotechnology in partnership with San Jacinto College. In The Woodlands, Alexandria is developing 8800 Technology Forest Place into 325,000 square feet of Class A space.   Initiatives such as the Cancer Prevention Research Institute of Texas (CPRIT) and a thriving innovation ecosystem further reinforce the city's position at the forefront of bioscience breakthroughs and economic impact.  With strategic advantages like its top-ranked port, diverse population, and accessibility to global markets, Houston is poised to further elevate its status as a hub for life sciences innovation. As Houston continues to advance its life sciences and biotechnology sector, opportunities for collaboration and growth abound, driving progress in public health and driving the next wave of bioscience innovation.   Explore Houston's dynamic life sciences ecosystem.  
Read More

Related Events

Economic Development

Life Sciences and Biotechnology Forum

The synthetic biology market, driven by research and development, is expected to grow significantly, with estimates suggesting it could reach $30 billion or more by 2030. Synthetic biology has the potential to…

Learn More
Learn More
Executive Partners